XTX Topco’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.2M Buy
289,670
+233,385
+415% +$18.7M 0.32% 10
2025
Q4
$5.37M Buy
56,285
+6,347
+13% +$622K 0.14% 110
2025
Q3
$4.88M Buy
+49,938
New +$5.17M 0.25% 32
2025
Q2
Sell
-66,516
Closed -$6.71M 2407
2025
Q1
$6.71M Buy
+66,516
New +$6.7M 0.34% 20
2024
Q4
Sell
-13,532
Closed -$1.13M 2326
2024
Q3
$1.13M Buy
+13,532
New +$1.07M 0.08% 370
2023
Q3
Sell
-31,671
Closed -$1.71M 1587
2023
Q2
$1.71M Buy
+31,671
New +$1.65M 0.31% 19
2023
Q1
Sell
-9,261
Closed -$429K 1294
2022
Q4
$429K Buy
+9,261
New +$401K 0.09% 374
2022
Q2
Sell
-6,967
Closed -$309K 864
2022
Q1
$309K Buy
+6,967
New +$302K 0.14% 258
2021
Q3
Sell
-26,052
Closed -$1.11M 714
2021
Q2
$1.11M Buy
+26,052
New +$1.1M 0.38% 28

Other funds holding BSX

XTX Topco's BSX Position: Q1 2026 in Review

XTX Topco increased its Boston Scientific (BSX) stake by 415% in Q1 2026, buying an estimated $18.7M and bringing the position to 289,670 shares worth $18.2M. The position accounts for 0.32% of the portfolio, ranked #10.

XTX Topco first reported a position in BSX in Q2 2021 and has held it in 9 quarters since. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • XTX Topco held 289,670 shares of Boston Scientific worth $18.2M as of Q1 2026.
  • XTX Topco bought 233,385 Boston Scientific shares in Q1 2026, an estimated $18.7M.
  • Boston Scientific made up 0.32% of XTX Topco's portfolio in Q1 2026, its #10 holding.
  • XTX Topco first reported a position in Boston Scientific in Q2 2021 and has held it in 9 quarters since.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.